Arzu Akşit İlki profile image
Arzu Akşit İlki Prof. Dr. Marmara Üniversitesi Tıp Fakültesi
Publication 3 Review 1 TR Dizin Cited 15
3 Publication
1 Review
15 TR Dizin Cited
0000-0003-3887-7003

Research Fields

Medical Infection Agents Health Sciences

Institution

Marmara Üniversitesi Tıp Fakültesi

Publications

Prevalence of Norovirus Coinfection in Clostridioides difficile Toxin Positive Patients
Authors: Hanife Şura Şalcı Aslan , Fatih Mehmet Akıllı , Elvan Sayin , Arzu Akşit İlki
Published: 2024 , Clinical and Experimental Health Sciences
DOI: 10.33808/clinexphealthsci.1478430
FAVORITE 0 TOTAL DOWNLOAD COUNT 146

0

146

Incidence of Rotavirus, Norovirus GI and GII genotypes and Adenovirus in Children with Acute Gastroenteritis
Authors: Yaşar Mercan , Esra Baran , Arzu Akşit İlki
Published: 2024 , Journal of Health Sciences and Management
DOI: -
FAVORITE 0 TOTAL DOWNLOAD COUNT 253

0

253

Tuberculosis and vitamin D
Authors: Arzu Akşit İlki
Published: 2014 , Marmara Medical Journal
DOI: -
FAVORITE 0 TOTAL DOWNLOAD COUNT 550

0

550

Articles published in
Clinical and Experimental Health Sciences
Clinical and Experimental Health Sciences
Journal of Health Sciences and Management
Journal of Health Sciences and Management
Marmara Medical Journal
Marmara Medical Journal
Editorship
Marmara Medical Journal
Marmara Medical Journal
Co-Editor
Editorial Board Memberships
Marmara Medical Journal
Marmara Medical Journal

Reviews

Clinical and Experimental Health Sciences
Clinical and Experimental Health Sciences
There are no Crossref cited.
Popular Publications: It is determined automatically by the researchers doing research in DergiPark according to the statistics of being added to the favorites. CrossRef Cited: The citations shown in DergiPark are drawn from CrossRef. For this, the cited and cited articles must be registered in CrossRef (DOI number). ^: Citation numbers are reflected in the system by DergiPark at certain periods.
Interactive Guide Tool
If you want to see the panel introduction, you can click Start Tour.